VisionPoint Advisory Group »

Soleno Therapeutics shares owned by VisionPoint Advisory Group

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by VisionPoint Advisory Group from 13F filings

Historical chart of VisionPoint Advisory Group investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by VisionPoint Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by VisionPoint Advisory Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.8k 168 40.25
2023-09-30 $5.0k 168 29.51
2023-06-30 $721 168 4.29

More positions owned by VisionPoint Advisory Group

Spdr Ser Tr Portfoli S&p1500 (SPTM)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Mortge Rel Etf (REM)
First Tr Nasdaq 100 Tech Ind SHS (QTEC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Deere & Company (DE)
Philip Morris International (PM)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)
Agnc Invt Corp Com reit (AGNC)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr Ser Tr Portfolio Short (SPSB)

View all positions for VisionPoint Advisory Group

Top funds holding Soleno Therapeutics

Vivo Capital
Perceptive Advisors
Carlyle
Nantahala Capital Management
Henderson Group
Vanguard Group
Balyasny Asset Management
venBio Select Advisor
Commodore Capital
Ikarian Capital
Frazier Life Sciences Management
Samlyn Capital
Emerald Advisers
Wellington Management Company
Emerald Mutual Fund Advisers, Trust

View all funds holding Soleno Therapeutics